应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
KPTI Karyopharm Therapeutics Inc.
盘前交易 04-22 06:45:43 EDT
5.40
+0.45
+9.09%
盘前
5.66
+0.26
+4.81%
05:02 EDT
最高
5.50
最低
4.89
成交量
8.14万
今开
4.89
昨收
4.95
日振幅
12.32%
总市值
4,545万
流通市值
3,910万
总股本
841.60万
成交额
43.35万
换手率
1.12%
流通股本
724.10万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Karyopharm Therapeutics Inc.盘中异动 早盘急速拉升6.06%
市场透视 · 04-21 14:18
Karyopharm Therapeutics Inc.盘中异动 早盘急速拉升6.06%
Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨6.11%报4.69美元
市场透视 · 04-17
Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨6.11%报4.69美元
Karyopharm Therapeutics Inc.盘中异动 大幅上涨5.75%报4.51美元
市场透视 · 04-16
Karyopharm Therapeutics Inc.盘中异动 大幅上涨5.75%报4.51美元
Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨5.22%报7.25美元
市场透视 · 03-10
Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨5.22%报7.25美元
Karyopharm Therapeutics Inc.盘中异动 临近午盘大幅跳水5.20%
市场透视 · 03-05
Karyopharm Therapeutics Inc.盘中异动 临近午盘大幅跳水5.20%
Karyopharm Therapeutics Inc.盘中异动 快速下跌5.09%报7.55美元
市场透视 · 03-03
Karyopharm Therapeutics Inc.盘中异动 快速下跌5.09%报7.55美元
Baird:维持Karyopharm Therapeutics(KPTI.US)评级,由优于大市调整至优于大市评级, 目标价由75.00美元调整至54.00美元。
金融界 · 03-03
Baird:维持Karyopharm Therapeutics(KPTI.US)评级,由优于大市调整至优于大市评级, 目标价由75.00美元调整至54.00美元。
Karyopharm Therapeutics Inc.盘中异动 临近午盘急速下挫5.15%报7.92美元
市场透视 · 02-28
Karyopharm Therapeutics Inc.盘中异动 临近午盘急速下挫5.15%报7.92美元
Karyopharm Therapeutics Inc.盘中异动 早盘大幅上涨5.49%报10.37美元
市场透视 · 02-27
Karyopharm Therapeutics Inc.盘中异动 早盘大幅上涨5.49%报10.37美元
Karyopharm Therapeutics Inc.盘中异动 股价大涨7.74%报9.23美元
市场透视 · 02-26
Karyopharm Therapeutics Inc.盘中异动 股价大涨7.74%报9.23美元
HC Wainwright & Co.:维持Karyopharm Therapeutics(KPTI.US)评级,由买入调整至买入评级, 目标价由7.00美元调整至56.00美元。
金融界 · 02-26
HC Wainwright & Co.:维持Karyopharm Therapeutics(KPTI.US)评级,由买入调整至买入评级, 目标价由7.00美元调整至56.00美元。
Karyopharm Therapeutics Inc.盘中异动 早盘股价大跌5.58%报0.562美元
市场透视 · 02-25
Karyopharm Therapeutics Inc.盘中异动 早盘股价大跌5.58%报0.562美元
Karyopharm Therapeutics Inc.盘中异动 股价大跌9.76%报0.540美元
市场透视 · 02-24
Karyopharm Therapeutics Inc.盘中异动 股价大跌9.76%报0.540美元
Karyopharm Therapeutics Inc.2024财年实现净利润-76.42百万美元,同比增加46.56%
市场透视 · 02-24
Karyopharm Therapeutics Inc.2024财年实现净利润-76.42百万美元,同比增加46.56%
Karyopharm Therapeutics Inc.盘中异动 早盘股价大跌9.29%报0.572美元
市场透视 · 02-19
Karyopharm Therapeutics Inc.盘中异动 早盘股价大跌9.29%报0.572美元
卡里奥制药公司 2024年第四季度GAAP每股亏损$0.24,超出$0.26的预期,销售额为$3054万,低于$3486万的预期
财报速递 · 02-19
卡里奥制药公司 2024年第四季度GAAP每股亏损$0.24,超出$0.26的预期,销售额为$3054万,低于$3486万的预期
Karyopharm Therapeutics Inc.盘中异动 股价大涨5.42%报0.650美元
市场透视 · 02-18
Karyopharm Therapeutics Inc.盘中异动 股价大涨5.42%报0.650美元
Karyopharm Therapeutics Inc.盘中异动 下午盘急速下挫5.27%报0.590美元
市场透视 · 02-11
Karyopharm Therapeutics Inc.盘中异动 下午盘急速下挫5.27%报0.590美元
Karyopharm Therapeutics Inc.盘中异动 大幅上涨5.09%
市场透视 · 02-10
Karyopharm Therapeutics Inc.盘中异动 大幅上涨5.09%
加载更多
公司概况
公司名称:
Karyopharm Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Karyopharm Therapeutics Inc.于2008年12月22日在特拉华州注册成立。该公司是一家临床阶段的制药公司,专注于发现和开发针对核转运靶点的新型一线药物,用于治疗癌症和重大疾病。该公司的科学专长集中在了解细胞核和细胞质之间细胞内运输的调节。该公司发现并开发了抑制核输出蛋白XPO1的全资、新型、小分子、核输出选择性抑制剂或SINE化合物。该公司的主要候选药物Selinexor(KPT-330)是一种XPO1抑制剂,正在多个开放标签的1期临床试验中接受评估,这些试验针对的是经过深度预处理的复发和难治性血液系统和实体瘤恶性肿瘤患者。
发行价格:
--
{"stockData":{"symbol":"KPTI","market":"US","secType":"STK","nameCN":"Karyopharm Therapeutics Inc.","latestPrice":5.4,"timestamp":1745265600000,"preClose":4.95,"halted":0,"volume":81398,"hourTrading":{"tag":"盘前","latestPrice":5.66,"preClose":5.4,"latestTime":"05:02 EDT","volume":2,"amount":11.32,"timestamp":1745312563689},"delay":0,"floatShares":7241011,"shares":8416007,"eps":-14.003887,"marketStatus":"盘前交易","change":0.45,"latestTime":"04-22 06:45:43 EDT","open":4.89,"high":5.5,"low":4.89,"amount":433527.668993,"amplitude":0.123232,"askPrice":5.75,"askSize":1,"bidPrice":4.18,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-14.003887,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745328600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1383714000000,"exchange":"NASDAQ","adjPreClose":5.4,"preHourTrading":{"tag":"盘前","latestPrice":5.66,"preClose":5.4,"latestTime":"05:02 EDT","volume":2,"amount":11.32,"timestamp":1745312563689},"postHourTrading":{"tag":"盘后","latestPrice":5.4,"preClose":5.4,"latestTime":"19:05 EDT","volume":79,"amount":426.43,"timestamp":1745276716106},"volumeRatio":0.8425641659251265,"impliedVol":3.3842,"impliedVolPercentile":0.9839},"requestUrl":"/m/hq/s/KPTI","defaultTab":"news","newsList":[{"id":"2529800241","title":"Karyopharm Therapeutics Inc.盘中异动 早盘急速拉升6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529800241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529800241?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:18","pubTimestamp":1745245133,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时18分,Karyopharm Therapeutics Inc.股票出现波动,股价快速拉升6.06%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.17%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421221853aa2c7450&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421221853aa2c7450&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KPTI","LENZ","BK4007"],"gpt_icon":0},{"id":"2528728747","title":"Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨6.11%报4.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528728747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528728747?lang=zh_cn&edition=full","pubTime":"2025-04-17 23:26","pubTimestamp":1744903611,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日23时26分,Karyopharm Therapeutics Inc.股票出现异动,股价快速拉升6.11%。截至发稿,该股报4.69美元/股,成交量1.4123万股,换手率0.16%,振幅6.15%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.64%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417232652aa2c734c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417232652aa2c734c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","KPTI","LENZ","BK4139"],"gpt_icon":0},{"id":"2528227010","title":"Karyopharm Therapeutics Inc.盘中异动 大幅上涨5.75%报4.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528227010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528227010?lang=zh_cn&edition=full","pubTime":"2025-04-17 01:07","pubTimestamp":1744823224,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日01时07分,Karyopharm Therapeutics Inc.股票出现波动,股价大幅上涨5.75%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.12%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417010704973a29e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417010704973a29e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","KPTI"],"gpt_icon":0},{"id":"2518822073","title":"Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨5.22%报7.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518822073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518822073?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:19","pubTimestamp":1741616363,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时19分,Karyopharm Therapeutics Inc.股票出现波动,股价快速上涨5.22%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.35%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221923abf30e51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221923abf30e51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KPTI","LENZ"],"gpt_icon":0},{"id":"2517944041","title":"Karyopharm Therapeutics Inc.盘中异动 临近午盘大幅跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517944041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517944041?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:43","pubTimestamp":1741193017,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时43分,Karyopharm Therapeutics Inc.股票出现异动,股价大幅跳水5.20%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.04%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306004337989d6422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306004337989d6422&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KPTI"],"gpt_icon":0},{"id":"2516658033","title":"Karyopharm Therapeutics Inc.盘中异动 快速下跌5.09%报7.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516658033?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:53","pubTimestamp":1741017185,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时53分,Karyopharm Therapeutics Inc.股票出现异动,股价急速跳水5.09%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.38%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032353069637c0fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032353069637c0fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KPTI","BK4139"],"gpt_icon":0},{"id":"2516335036","title":"Baird:维持Karyopharm Therapeutics(KPTI.US)评级,由优于大市调整至优于大市评级, 目标价由75.00美元调整至54.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516335036","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516335036?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:51","pubTimestamp":1741006293,"startTime":"0","endTime":"0","summary":"Baird:维持Karyopharm Therapeutics(KPTI.US)评级,由优于大市调整至优于大市评级, 目标价由75.00美元调整至54.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03205148492763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","KPTI"],"gpt_icon":0},{"id":"2516371793","title":"Karyopharm Therapeutics Inc.盘中异动 临近午盘急速下挫5.15%报7.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516371793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516371793?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:46","pubTimestamp":1740761178,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时46分,Karyopharm Therapeutics Inc.股票出现波动,股价大幅下跌5.15%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.33%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030100461898969801&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030100461898969801&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KPTI"],"gpt_icon":0},{"id":"2514387366","title":"Karyopharm Therapeutics Inc.盘中异动 早盘大幅上涨5.49%报10.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514387366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514387366?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:14","pubTimestamp":1740672884,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时14分,Karyopharm Therapeutics Inc.股票出现异动,股价快速上涨5.49%。截至发稿,该股报10.37美元/股,成交量10.3353万股,换手率1.23%,振幅9.36%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.57%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228001444a25693d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228001444a25693d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","LENZ","BK4139"],"gpt_icon":0},{"id":"2514859852","title":"Karyopharm Therapeutics Inc.盘中异动 股价大涨7.74%报9.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514859852?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:38","pubTimestamp":1740580689,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时38分,Karyopharm Therapeutics Inc.股票出现波动,股价大幅上涨7.74%。截至发稿,该股报9.23美元/股,成交量1.793万股,换手率0.21%,振幅6.07%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.57%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262238099631506b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262238099631506b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KPTI","BK4139"],"gpt_icon":0},{"id":"2514893832","title":"HC Wainwright & Co.:维持Karyopharm Therapeutics(KPTI.US)评级,由买入调整至买入评级, 目标价由7.00美元调整至56.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514893832","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514893832?lang=zh_cn&edition=full","pubTime":"2025-02-26 20:41","pubTimestamp":1740573703,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持Karyopharm Therapeutics(KPTI.US)评级,由买入调整至买入评级, 目标价由7.00美元调整至56.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26204148411567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","KPTI"],"gpt_icon":0},{"id":"2514013593","title":"Karyopharm Therapeutics Inc.盘中异动 早盘股价大跌5.58%报0.562美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514013593?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:51","pubTimestamp":1740495082,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时51分,Karyopharm Therapeutics Inc.股票出现波动,股价急速下跌5.58%。截至发稿,该股报0.562美元/股,成交量9.8686万股,换手率0.08%,振幅5.90%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.06%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522512498925166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522512498925166&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KPTI","BK4139"],"gpt_icon":0},{"id":"2513372732","title":"Karyopharm Therapeutics Inc.盘中异动 股价大跌9.76%报0.540美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513372732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513372732?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:31","pubTimestamp":1740407467,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时31分,Karyopharm Therapeutics Inc.股票出现波动,股价急速下挫9.76%。截至发稿,该股报0.540美元/股,成交量33.4268万股,换手率0.26%,振幅0.00%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.12%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223107a25213eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223107a25213eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KPTI"],"gpt_icon":0},{"id":"2513925587","title":"Karyopharm Therapeutics Inc.2024财年实现净利润-76.42百万美元,同比增加46.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513925587","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513925587?lang=zh_cn&edition=full","pubTime":"2025-02-24 13:00","pubTimestamp":1740373220,"startTime":"0","endTime":"0","summary":"2月24日,Karyopharm Therapeutics Inc.公布财报,公告显示公司2024财年净利润为-76.42百万美元,同比增加46.56%;其中营业收入为1.45亿美元,同比减少0.68%,每股基本收益为-0.63美元。机构评级:截至2025年2月24日,当前有7家机构对Karyopharm Therapeutics Inc.目标价做出预测,其中目标均价为4.50美元,其中最低目标价为2.00美元,最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224130025abda6b1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224130025abda6b1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","LENZ"],"gpt_icon":0},{"id":"2512483656","title":"Karyopharm Therapeutics Inc.盘中异动 早盘股价大跌9.29%报0.572美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512483656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512483656?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:31","pubTimestamp":1739975487,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时31分,Karyopharm Therapeutics Inc.股票出现波动,股价大幅跳水9.29%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.15%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223127988b3145&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223127988b3145&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KPTI","BK4139"],"gpt_icon":0},{"id":"1160040103","title":"卡里奥制药公司 2024年第四季度GAAP每股亏损$0.24,超出$0.26的预期,销售额为$3054万,低于$3486万的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1160040103","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160040103?lang=zh_cn&edition=full","pubTime":"2025-02-19 20:34","pubTimestamp":1739968463,"startTime":"0","endTime":"0","summary":"卡里奥制药公司报告称,其季度每股亏损为$0.24,好于分析师一致预期的$0.26,超出7.69%。公司报告季度销售额为$3054万,低于分析师一致预期的$3486万,差距为12.40%。相比去年同期销售额$3375万,减少了9.50%。以上内容来自Benzinga Earnings专栏,原文如下:Karyopharm $Therapeutics$ reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 7.69 percent. This is a 33.33 percent increase over losses of $ per share from the same period last year. The company reported quarterly sales of $30.54 million which missed the analyst consensus estimate of $34.86 million by 12.40 ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"卡里奥制药公司 2024年第四季度GAAP每股亏损$0.24,超出$0.26的预期,销售额为$3054万,低于$3486万的预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI"],"gpt_icon":0},{"id":"2512161825","title":"Karyopharm Therapeutics Inc.盘中异动 股价大涨5.42%报0.650美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512161825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512161825?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:53","pubTimestamp":1739890421,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时53分,Karyopharm Therapeutics Inc.股票出现波动,股价快速拉升5.42%。截至发稿,该股报0.650美元/股,成交量15.4062万股,换手率0.12%,振幅4.05%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.99%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225341a24ab1bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225341a24ab1bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KPTI"],"gpt_icon":0},{"id":"2510440353","title":"Karyopharm Therapeutics Inc.盘中异动 下午盘急速下挫5.27%报0.590美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510440353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510440353?lang=zh_cn&edition=full","pubTime":"2025-02-12 02:30","pubTimestamp":1739298616,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日02时30分,Karyopharm Therapeutics Inc.股票出现波动,股价快速下跌5.27%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.79%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212023016a2422e4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212023016a2422e4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KPTI","BK4139"],"gpt_icon":0},{"id":"2510056865","title":"Karyopharm Therapeutics Inc.盘中异动 大幅上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510056865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510056865?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:59","pubTimestamp":1739199558,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时59分,Karyopharm Therapeutics Inc.股票出现波动,股价急速拉升5.09%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.32%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225918961e05ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225918961e05ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KPTI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.karyopharm.com","stockEarnings":[{"period":"1week","weight":0.2827},{"period":"1month","weight":-0.1589},{"period":"3month","weight":-0.4759},{"period":"6month","weight":-0.5756},{"period":"1year","weight":-0.6923},{"period":"ytd","weight":-0.4677}],"compareEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.1109},{"period":"1year","weight":0.0378},{"period":"ytd","weight":-0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Karyopharm Therapeutics Inc.于2008年12月22日在特拉华州注册成立。该公司是一家临床阶段的制药公司,专注于发现和开发针对核转运靶点的新型一线药物,用于治疗癌症和重大疾病。该公司的科学专长集中在了解细胞核和细胞质之间细胞内运输的调节。该公司发现并开发了抑制核输出蛋白XPO1的全资、新型、小分子、核输出选择性抑制剂或SINE化合物。该公司的主要候选药物Selinexor(KPT-330)是一种XPO1抑制剂,正在多个开放标签的1期临床试验中接受评估,这些试验针对的是经过深度预处理的复发和难治性血液系统和实体瘤恶性肿瘤患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.007822},{"month":2,"riseRate":0.583333,"avgChangeRate":0.021466},{"month":3,"riseRate":0.583333,"avgChangeRate":0.056308},{"month":4,"riseRate":0.25,"avgChangeRate":-0.060136},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.013174},{"month":6,"riseRate":0.545455,"avgChangeRate":0.010739},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.018973},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.022599},{"month":9,"riseRate":0.545455,"avgChangeRate":-0.010356},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.034599},{"month":11,"riseRate":0.727273,"avgChangeRate":0.140432},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.102143}],"exchange":"NASDAQ","name":"Karyopharm Therapeutics Inc.","nameEN":"Karyopharm Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Karyopharm Therapeutics Inc.(KPTI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Karyopharm Therapeutics Inc.(KPTI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Karyopharm Therapeutics Inc.,KPTI,Karyopharm Therapeutics Inc.股票,Karyopharm Therapeutics Inc.股票老虎,Karyopharm Therapeutics Inc.股票老虎国际,Karyopharm Therapeutics Inc.行情,Karyopharm Therapeutics Inc.股票行情,Karyopharm Therapeutics Inc.股价,Karyopharm Therapeutics Inc.股市,Karyopharm Therapeutics Inc.股票价格,Karyopharm Therapeutics Inc.股票交易,Karyopharm Therapeutics Inc.股票购买,Karyopharm Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Karyopharm Therapeutics Inc.(KPTI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Karyopharm Therapeutics Inc.(KPTI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}